NCT01956591

Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis

Retrospective Evaluation of Long Term Use of Oxybutynin in the Pharmacological Treatment of Primary Hyperhidrosis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,100 (actual)
• Sponsor: Hospital Israelita Albert Einstein · Academic / Other
• Sex: All
• Age: 5 Years
• Healthy volunteers: Not accepted

Summary

Evaluate the long term efficacy and side effects of oxybutynin in the treatment of hyperhidrosis.

Detailed description

This retrospective study aims to evaluate the medical charts of patients who were treated with oxybutynin for at least six months for primary hyperhidrosis. The investigators variables of interest are: (1) quality of life before pharmacological therapy and after six weeks, (2)self-perception of improvement in hyperhidrosis after six weeks of treatment and on last visit (whenever this occur, as long as this happens after six months), (3) side effects related to drug use.

Conditions

• Hyperhidrosis

Interventions

Type	Name	Description
DRUG	Oxybutynin	All patients are treated with oxybutynin for hyperhidrosis. Usual maintenance dose is 10mg/day, but dose may vary according to weight, efficacy and side effects. Our standard protocol starts with 2.5mg/day in the first 7 days, progresses to 5mg/day for 14 days and then reaches the usual maintenance dose of 10mg/day afterwards.

Timeline

• Start date: 2007-09-01
• Primary completion: 2013-09-01
• Completion: 2013-09-01
• First posted: 2013-10-08
• Last updated: 2013-10-08

Locations

1 site across 1 country: Brazil